Pierre Fabre
Phone: +33 1 53 53 20 50
Web: https://www.pierre-fabre.com
| Type | Private limited company |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1951 (1951) |
| Headquarters | Paris, France |
| Area served | Worldwide |
| Key people |
|
| Number of employees | 13,000 (2015) (Homepage) |
| Website | www.pierre-fabre.com |
The Pierre Fabre Group is a pioneer on the French industrial scene. Why? A Foundation of the same name, recognized as being of public interest, has been the main Group shareholder since 2013. This unique shareholding structure guarantees the company's independence and helps us favor the longterm over the short term, in line with our founder's principles.
For detailed contact information visit location pages below.
Pierre Fabre's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Pierre Fabre
-
Pierre Fabre MedicamentPierre Fabre Pharma GmbHCompleted
-
Pierre Fabre Medical DevicesCompleted
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMelanoma Stage IV | Melanoma Stage IIIAustria, Germany, Switzerland
-
Pierre Fabre MedicamentRecruitingStudy of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs (STX-241 FIH)Non-small Cell Lung Cancer (NSCLC)Taiwan, Spain, France, Netherlands, China, United States, Germany
-
Pierre Fabre MedicamentCompletedMetastatic Melanoma | Melanoma (Skin) | BRAF V600 MutationPortugal
-
Pierre Fabre MedicamentCompletedOsteoarthritis, KneePoland
-
Pierre Fabre MedicamentTerminatedAdvanced or Metastatic Solid TumorsFrance, Spain
-
Pierre Fabre MedicamentCompleted
-
Pierre Fabre MedicamentCompletedBreast Cancer | MetastasesFrance, Ukraine, United Kingdom, Germany, Taiwan, Spain, Belarus, Belgium, Portugal, South Africa, Russian Federation, Austria, Italy, Argentina
-
Pierre Fabre MedicamentCompleted